Net Loss Per Share (Tables)

3 Months Ended

12 Months Ended

Mar. 31, 2026

Sep. 30, 2025

Schedule of Earnings Per Share Basic and Diluted

		Class A			Class B			Class A			Class B
	Three months ended March 31,
	2026						2025
		Class A			Class B			Class A			Class B
Basic net loss per share:
Numerator:
Allocation of net loss	$	(5,734	)	$	(119	)	$	(2,177	)	$	(114	)
Denominator:
Weighted-average shares outstanding		9,638,233			200,491			3,822,890			200,491
Basic net loss per share	$	(0.59	)	$	(0.59	)	$	(0.57	)	$	(0.57	)

Diluted net loss per share:
Numerator:
Allocation of net loss	$	(5,734	)	$	(119	)	$	(2,177	)	$	(114	)
Reallocation of net loss as a result of conversion of Class B to Class A Common Stock		(119	)		—			(114	)		—
Allocation of net loss	$	(5,853	)	$	(119	)	$	(2,291	)	$	(114	)

Denominator:
Number of shares used in basic earnings per share calculation		9,638,233			200,491			3,822,890			200,491
Conversion of Class B to Class A Common Stock		200,491			—			200,491			—
Number of shares used in per share computation		9,838,724			200,491			4,023,381			200,491
Diluted net loss per share	$	(0.59	)	$	(0.59	)	$	(0.57	)	$	(0.57	)

		Class A			Class B			Class A			Class B
	Six months ended March 31,
	2026						2025
		Class A			Class B			Class A			Class B
Basic net loss per share:
Numerator:
Allocation of net loss	$	(15,580	)	$	(398	)	$	(20,974	)	$	(1,156	)
Denominator:
Weighted-average shares outstanding		7,857,772			200,491			3,726,645			205,367
Basic net loss per share	$	(1.98	)	$	(1.98	)	$	(5.63	)	$	(5.63	)

Diluted net loss per share:
Numerator:
Allocation of net loss	$	(15,580	)	$	(398	)	$	(20,974	)	$	(1,156	)
Reallocation of net loss as a result of conversion of Class B to Class A Common Stock		(398	)		—			(1,156	)		—
Allocation of net loss	$	(15,978	)	$	(398	)	$	(22,130	)	$	(1,156	)

Denominator:
Number of shares used in basic earnings per share calculation		7,857,772			200,491			3,726,645			205,367
Conversion of Class B to Class A Common Stock		200,491			—			205,367			—
Number of shares used in per share computation		8,058,263			200,491			3,932,012			205,367
Diluted net loss per share	$	(1.98	)	$	(1.98	)	$	(5.63	)	$	(5.63	)

	Class A			Class B			Class A			Class B
	Year ended September 30,
	2025						2024
	Class A			Class B			Class A			Class B
Basic net loss per share:
Numerator:
Allocation of net loss	$	(44,072	)	$	(2,059	)	$	(18,452	)	$	(1,582	)
Deemed dividend from warrant price adjustment		—			—			(609	)		(52	)
Net loss available to common stockholders	$	(44,072	)	$	(2,059	)	$	(19,061	)	$	(1,634	)
Denominator:
Weighted-average shares outstanding		4,343,588			202,921			2,617,527			224,431
Basic net loss per share	$	(10.15	)	$	(10.15	)	$	(7.28	)	$	(7.28	)

Diluted net loss per share:
Numerator:
Net loss available to common stockholders	$	(44,072	)	$	(2,059	)	$	(19,061	)	$	(1,634	)
Change in fair value of PIPE make-whole liability		—			—			(764	)		(66	)
Change in fair value of liability-classified warrants		—			—			(634	)		(54	)
Reallocation of net loss as a result of conversion of Class B to Class A Common Stock		(2,059	)		—			(1,754	)		—
Reallocation of net loss as a result of conversion of Class B to Class A Common Stock		—			—			—			63
Allocation of net loss	$	(46,131	)	$	(2,059	)	$	(22,213	)	$	(1,691	)
Denominator:
Number of shares used in basic earnings per share calculation		4,343,588			202,921			2,617,527			224,431
Shares issuable in satisfaction of PIPE make-whole liability		—			—			72,722			—
Shares issuable under liability-classified warrants		—			—			33,620			—
Conversion of Class B to Class A Common Stock		202,921			—			224,431			—
Number of shares used in per share computation		4,546,509			202,921			2,948,302			224,431
Diluted net loss per share	$	(10.15	)	$	(10.15	)	$	(7.53	)	$	(7.53	)

Schedule of Antidilutive Shares

The potential shares of Class A Common Stock that were excluded from the computation of diluted net loss per share for the periods presented because including them would have an antidilutive effect were as follows:

Schedule of Antidilutive Shares

	2026		2025
	Six months ended March 31,
	2026		2025
Warrants		2,608,568		1,551,878
Shares potentially issuable under earnout arrangements		350,000		414,281
RSAs		416,250		—
RSUs		559,732		622,824
Stock options		210,321		262,480
Total		4,144,871		2,851,463

Schedule of Antidilutive Shares

	2025		2024
	Year ended September 30,
	2025		2024

Public Warrants and Private Warrants		900,000		900,000
Other common stock warrants		1,570,568		751,878
Earnout Shares		350,000		350,000
Shares potentially issuable under Rage Earnout		64,280		128,560
RSAs		487,250		—
RSUs		954,599		446,318
Stock options		245,218		274,063
Total		4,571,915		2,850,819

MOBIX LABS, INC S-1/A